cancer treatments
http://www.yso.fi/onto/yso/p27422
Related publications and other outputs
1 of 3
- Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy : synthesis, evaluation, and molecular modelling studies (2024) Islam, Mohammad Shahidul; et al.; A1
- High immune cell infiltration predicts improved survival in cholangiocarcinoma (2024) Wirta, Erkki-Ville; et al.; A1; OA
- Production study of Fr, Ra and Ac radioactive ion beams at ISOLDE, CERN (2024) Jajčišinová, E.; et al.; A1; OA
- Rational Design of Targeted Gold Nanoclusters with High Affinity to Integrin αvβ3 for Combination Cancer Therapy (2024) Matus, María Francisca; et al.; A1; OA
- The roles of immune cell composition and immunosuppressive factors in the colorectal cancer microenvironment (2024) Elomaa, Hanna; G5; OA; 978-952-86-0244-6
- Transdermal oestradiol and exercise in androgendeprivation therapy (ESTRACISE) : protocol (2024) Jussila, Ilkka; et al.; A1; OA
- Influence of Initial Multiple Myeloma Treatment on Immune Cell Repertoires, Recovery and Diversity (2022) Saari, Minna; et al.; O1; OA
- Novel spirooxindole based benzimidazole scaffold : In vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma (2022) Barakat, Assem; et al.; A1
- Irradiation of the head reduces adult hippocampal neurogenesis and impairs spatial memory, but leaves overall health intact in rats (2021) Lensu, Sanna; et al.; A1; OA
- Ligand Ratio Plays a Critical Role in the Design of Optimal Multifunctional Gold Nanoclusters for Targeted Gastric Cancer Therapy (2021) Matus, María Francisca; et al.; A1; OA
